Photodynamic therapy with a novel photosensitizer inhibits DSS-induced ulcerative colitis in rats via the NF-κB signaling pathway

IntroductionUlcerative colitis (UC) is an inflammatory bowel disease characterized by inflammation and ulceration of the digestive tract.MethodsPhotodynamic therapy (PDT) with a novel photosensitizer LD4 was used to treat UC rat models to explore the therapeutic effect and mechanism of LD4-PDT on UC...

Full description

Saved in:
Bibliographic Details
Main Authors: Yumei Rong, Minghui Zhu, Nan Wang, Feiyu Zhang, Tianjun Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2024.1539363/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841555159509893120
author Yumei Rong
Yumei Rong
Yumei Rong
Yumei Rong
Yumei Rong
Minghui Zhu
Minghui Zhu
Minghui Zhu
Minghui Zhu
Nan Wang
Nan Wang
Nan Wang
Nan Wang
Feiyu Zhang
Feiyu Zhang
Feiyu Zhang
Feiyu Zhang
Tianjun Liu
author_facet Yumei Rong
Yumei Rong
Yumei Rong
Yumei Rong
Yumei Rong
Minghui Zhu
Minghui Zhu
Minghui Zhu
Minghui Zhu
Nan Wang
Nan Wang
Nan Wang
Nan Wang
Feiyu Zhang
Feiyu Zhang
Feiyu Zhang
Feiyu Zhang
Tianjun Liu
author_sort Yumei Rong
collection DOAJ
description IntroductionUlcerative colitis (UC) is an inflammatory bowel disease characterized by inflammation and ulceration of the digestive tract.MethodsPhotodynamic therapy (PDT) with a novel photosensitizer LD4 was used to treat UC rat models to explore the therapeutic effect and mechanism of LD4-PDT on UC. 16S ribosomal RNA was used to detect the composition of Gut microbiota.ResultsOur findings indicate that LD4-PDT could protect the integrity of the colonic mucosa, alleviate the inflammatory response and promote the healing of colonic mucosa. Mechanism studies demonstrated that LD4-PDT could inhibit the NF-κB signaling pathway, downregulated the expression of the inflammatory factors’ tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) and myeloperoxidase (MPO), increased the contents of glutathione (GSH) and superoxide dismutase (SOD) and decreased the content of malondialdehyde (MDA). Additionally, analysis of gut microbiota revealed that LD4-PDT treatment could decrease the abundance of the Proteobacteria phylum in fecal samples, while no significant differences were observed in the Firmicutes, Bacteroidetes, or Actinobacteria phyla among the three groups using 16S rRNA analysis.DiscussionIn summary, our data suggested that LD4-PDT could inhibit DSS-induced UC in rats via the NF-κB signaling pathway, indicating its potential as a novel photosensitizer for the treatment of UC.
format Article
id doaj-art-4e1302ad3442445a8f03a116fcb89ef9
institution Kabale University
issn 1663-9812
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj-art-4e1302ad3442445a8f03a116fcb89ef92025-01-08T06:11:43ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122025-01-011510.3389/fphar.2024.15393631539363Photodynamic therapy with a novel photosensitizer inhibits DSS-induced ulcerative colitis in rats via the NF-κB signaling pathwayYumei Rong0Yumei Rong1Yumei Rong2Yumei Rong3Yumei Rong4Minghui Zhu5Minghui Zhu6Minghui Zhu7Minghui Zhu8Nan Wang9Nan Wang10Nan Wang11Nan Wang12Feiyu Zhang13Feiyu Zhang14Feiyu Zhang15Feiyu Zhang16Tianjun Liu17The Third Central Hospital of Tianjin, Tianjin, ChinaTianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Tianjin, ChinaArtificial Cell Engineering Technology Research Center, Tianjin, ChinaTianjin Institute of Hepatobiliary Disease, Tianjin, ChinaTianjin Key Laboratory of Biomedical Material, Institute of Biomedical Engineering, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, ChinaThe Third Central Hospital of Tianjin, Tianjin, ChinaTianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Tianjin, ChinaArtificial Cell Engineering Technology Research Center, Tianjin, ChinaTianjin Institute of Hepatobiliary Disease, Tianjin, ChinaThe Third Central Hospital of Tianjin, Tianjin, ChinaTianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Tianjin, ChinaArtificial Cell Engineering Technology Research Center, Tianjin, ChinaTianjin Institute of Hepatobiliary Disease, Tianjin, ChinaThe Third Central Hospital of Tianjin, Tianjin, ChinaTianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Tianjin, ChinaArtificial Cell Engineering Technology Research Center, Tianjin, ChinaTianjin Institute of Hepatobiliary Disease, Tianjin, ChinaTianjin Key Laboratory of Biomedical Material, Institute of Biomedical Engineering, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, ChinaIntroductionUlcerative colitis (UC) is an inflammatory bowel disease characterized by inflammation and ulceration of the digestive tract.MethodsPhotodynamic therapy (PDT) with a novel photosensitizer LD4 was used to treat UC rat models to explore the therapeutic effect and mechanism of LD4-PDT on UC. 16S ribosomal RNA was used to detect the composition of Gut microbiota.ResultsOur findings indicate that LD4-PDT could protect the integrity of the colonic mucosa, alleviate the inflammatory response and promote the healing of colonic mucosa. Mechanism studies demonstrated that LD4-PDT could inhibit the NF-κB signaling pathway, downregulated the expression of the inflammatory factors’ tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) and myeloperoxidase (MPO), increased the contents of glutathione (GSH) and superoxide dismutase (SOD) and decreased the content of malondialdehyde (MDA). Additionally, analysis of gut microbiota revealed that LD4-PDT treatment could decrease the abundance of the Proteobacteria phylum in fecal samples, while no significant differences were observed in the Firmicutes, Bacteroidetes, or Actinobacteria phyla among the three groups using 16S rRNA analysis.DiscussionIn summary, our data suggested that LD4-PDT could inhibit DSS-induced UC in rats via the NF-κB signaling pathway, indicating its potential as a novel photosensitizer for the treatment of UC.https://www.frontiersin.org/articles/10.3389/fphar.2024.1539363/fullulcerative colitisDSSoxidative stressNF-κB signaling pathwaygut microbiota
spellingShingle Yumei Rong
Yumei Rong
Yumei Rong
Yumei Rong
Yumei Rong
Minghui Zhu
Minghui Zhu
Minghui Zhu
Minghui Zhu
Nan Wang
Nan Wang
Nan Wang
Nan Wang
Feiyu Zhang
Feiyu Zhang
Feiyu Zhang
Feiyu Zhang
Tianjun Liu
Photodynamic therapy with a novel photosensitizer inhibits DSS-induced ulcerative colitis in rats via the NF-κB signaling pathway
Frontiers in Pharmacology
ulcerative colitis
DSS
oxidative stress
NF-κB signaling pathway
gut microbiota
title Photodynamic therapy with a novel photosensitizer inhibits DSS-induced ulcerative colitis in rats via the NF-κB signaling pathway
title_full Photodynamic therapy with a novel photosensitizer inhibits DSS-induced ulcerative colitis in rats via the NF-κB signaling pathway
title_fullStr Photodynamic therapy with a novel photosensitizer inhibits DSS-induced ulcerative colitis in rats via the NF-κB signaling pathway
title_full_unstemmed Photodynamic therapy with a novel photosensitizer inhibits DSS-induced ulcerative colitis in rats via the NF-κB signaling pathway
title_short Photodynamic therapy with a novel photosensitizer inhibits DSS-induced ulcerative colitis in rats via the NF-κB signaling pathway
title_sort photodynamic therapy with a novel photosensitizer inhibits dss induced ulcerative colitis in rats via the nf κb signaling pathway
topic ulcerative colitis
DSS
oxidative stress
NF-κB signaling pathway
gut microbiota
url https://www.frontiersin.org/articles/10.3389/fphar.2024.1539363/full
work_keys_str_mv AT yumeirong photodynamictherapywithanovelphotosensitizerinhibitsdssinducedulcerativecolitisinratsviathenfkbsignalingpathway
AT yumeirong photodynamictherapywithanovelphotosensitizerinhibitsdssinducedulcerativecolitisinratsviathenfkbsignalingpathway
AT yumeirong photodynamictherapywithanovelphotosensitizerinhibitsdssinducedulcerativecolitisinratsviathenfkbsignalingpathway
AT yumeirong photodynamictherapywithanovelphotosensitizerinhibitsdssinducedulcerativecolitisinratsviathenfkbsignalingpathway
AT yumeirong photodynamictherapywithanovelphotosensitizerinhibitsdssinducedulcerativecolitisinratsviathenfkbsignalingpathway
AT minghuizhu photodynamictherapywithanovelphotosensitizerinhibitsdssinducedulcerativecolitisinratsviathenfkbsignalingpathway
AT minghuizhu photodynamictherapywithanovelphotosensitizerinhibitsdssinducedulcerativecolitisinratsviathenfkbsignalingpathway
AT minghuizhu photodynamictherapywithanovelphotosensitizerinhibitsdssinducedulcerativecolitisinratsviathenfkbsignalingpathway
AT minghuizhu photodynamictherapywithanovelphotosensitizerinhibitsdssinducedulcerativecolitisinratsviathenfkbsignalingpathway
AT nanwang photodynamictherapywithanovelphotosensitizerinhibitsdssinducedulcerativecolitisinratsviathenfkbsignalingpathway
AT nanwang photodynamictherapywithanovelphotosensitizerinhibitsdssinducedulcerativecolitisinratsviathenfkbsignalingpathway
AT nanwang photodynamictherapywithanovelphotosensitizerinhibitsdssinducedulcerativecolitisinratsviathenfkbsignalingpathway
AT nanwang photodynamictherapywithanovelphotosensitizerinhibitsdssinducedulcerativecolitisinratsviathenfkbsignalingpathway
AT feiyuzhang photodynamictherapywithanovelphotosensitizerinhibitsdssinducedulcerativecolitisinratsviathenfkbsignalingpathway
AT feiyuzhang photodynamictherapywithanovelphotosensitizerinhibitsdssinducedulcerativecolitisinratsviathenfkbsignalingpathway
AT feiyuzhang photodynamictherapywithanovelphotosensitizerinhibitsdssinducedulcerativecolitisinratsviathenfkbsignalingpathway
AT feiyuzhang photodynamictherapywithanovelphotosensitizerinhibitsdssinducedulcerativecolitisinratsviathenfkbsignalingpathway
AT tianjunliu photodynamictherapywithanovelphotosensitizerinhibitsdssinducedulcerativecolitisinratsviathenfkbsignalingpathway